Healthcare -
Biotechnology - NASDAQ - US
$ 1.82
-1.09 %
$ 382 M
Market Cap
-1.17
P/E
ALLO - COST OF REVENUE
Cost of Revenue ALLO - Allogene Therapeutics, Inc.
243 M
LAST VALUE
331.19%
2 YEAR CAGR
176.61%
5 YEAR CAGR
0.00%
10 YEAR CAGR